MEGUIAR'S M85 - Manual (Page 16)

M85, Diamond Cut Compound 2.0 (21-97A): M8501, M8532
__________________________________________________________________________________________
Page: 16 of 17
15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture
Carcinogenicity
Ingredient CAS Nbr Classification Regulation
Morpholine 110-91-8 Gr. 3: Not classifiable International Agency
for Research on Cancer
Global inventory status
Contact manufacturer for more information The components of this material are in compliance with the provisions of the
Korean Toxic Chemical Control Law. Certain restrictions may apply. Contact the selling division for additional information.
The components of this material are in compliance with the provisions of Australia National Industrial Chemical Notification
and Assessment Scheme (NICNAS). Certain restrictions may apply. Contact the selling division for additional information.
The components of this material are in compliance with the provisions of Philippines RA 6969 requirements. Certain
restrictions may apply. Contact the selling division for additional information. The components of this product are in
compliance with the new substance notification requirements of CEPA. The components of this product are in compliance
with the chemical notification requirements of TSCA.
15.2. Chemical Safety Assessment
Not applicable
SECTION 16: Other information
List of relevant H statements
EUH066 Repeated exposure may cause skin dryness or cracking.
H226 Flammable liquid and vapour.
H302 Harmful if swallowed.
H304 May be fatal if swallowed and enters airways.
H311 Toxic in contact with skin.
H314 Causes severe skin burns and eye damage.
H332 Harmful if inhaled.
H336 May cause drowsiness or dizziness.
List of relevant R-phrases
R10 Flammable.
R20 Harmful by inhalation.
R21 Harmful in contact with skin.
R22 Harmful if swallowed.
R34 Causes burns.
R65 Harmful: May cause lung damage if swallowed.
R66 Repeated exposure may cause skin dryness or cracking.
R67 Vapours may cause drowsiness and dizziness.
Revision information:
Revision Changes:
Section 8: Respiratory protection - recommended respirators information was modified.
Section 16: List of relevant R phrase information was modified.
Section 3: Composition/ Information of ingredients table was modified.
Section 2: Label remarks was modified.
Section 16: Regulations – Inventories – EU ONLY was modified.
Copyright was modified.
Aspiration Hazard Table was modified.
Section 11: Acute Toxicity table was modified.
Carcinogenicity Table was modified.